Pacira Biosciences
PCRX
#5836
Rank
ยฃ0.80 B
Marketcap
ยฃ18.00
Share price
0.04%
Change (1 day)
20.23%
Change (1 year)
Categories

Operating Margin for Pacira Biosciences (PCRX)

Operating Margin as of December 2025 (TTM): 5.83%

According to Pacira Biosciences 's latest financial reports and stock price the company's current Operating Margin is 5.83%. At the end of 2024 the company had an Operating Margin of -7.09%.

Operating Margin history for Pacira Biosciences from 2010 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-7.09%-160.53%
202311.71%59.7%
20227.33%-53.52%
202115.77%55.39%
202010.15%282.43%
20192.65%-55%
20185.90%-165.5%
2017-9.00%-20.75%
2016-11.36%-406.45%
20153.71%-224.51%
2014-2.98%-95.59%
2013-67.43%-47.78%
2012-129.14%-47.44%
2011-245.70%54.29%
2010-159.25%-16.29%
2009-190.24%-41.6%
2008-325.77%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Recro Pharma
REPH
4.99%-14.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-1,456.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-879.80%-15,190.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-8.75%-250.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-467.67%-8,121.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-259.55%-4,552.01%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.